Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,551.08
(
-0.84%
)
US TECH 100
23,459.60
(
-1.10%
)
Dow Jones
45,796.35
(
-0.49%
)
Brent Oil
106.69
(
2.16%
)
Bitcoin
69,942.00
(
0.07%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11870
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: DewDiligence post# 171576

Thursday, 12/19/2013 10:44:16 PM

Thursday, December 19, 2013 10:44:16 PM

Post# of 257262
Dew

Note that NVS’ Humira-FoB program, which is using the conventional BLA pathway in the US, is not seeking US interchangeability with branded Humira. This makes it a very different business proposition from what BAX/MNTA are attempting to do with their FoB compounds.



That is understood, but I'd guess their pathway will also be many years faster.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today